Inactive Instrument
NovImmune SA Stock
Stocks
IPO-NOVI
CH0010924170
Biotechnology & Medical Research
|
End-of-day quote
Swiss Exchange
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Nicolas Fischer
CEO | Chief Executive Officer | - | 2019-06-30 |
Nathalie Muller
ADM | Chief Administrative Officer | - | 1999-12-31 |
Hartmut Wekerle
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 81 | 2008-01-31 | |
| Director/Board Member | - | - | |
Tuygan Göker
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | -5.97% | +50.26% | +76.20% | 70.65B | |
| -1.99% | -13.92% | +3.01% | +51.60% | 51.22B | |
| -1.32% | -1.70% | +6.99% | +35.47% | 48.04B | |
| -0.25% | +0.92% | +28.76% | +31.60% | 43.16B | |
| -2.92% | -5.44% | +287.69% | +531.90% | 41.57B | |
| -0.19% | -3.29% | +7.29% | +96.24% | 39.84B | |
| -0.39% | -1.59% | +8.69% | +42.99% | 30.87B | |
| -2.66% | -7.49% | +35.37% | +3.22% | 27.53B | |
| -6.19% | -6.37% | -12.39% | -13.47% | 24.08B | |
| Average | -1.78% | -3.92% | +46.18% | +95.08% | 41.88B | |
| Weighted average by Cap. | -1.46% | -4.29% | +49.01% | +101.16% |
Employees
-
- Stock Market
- Stocks
- IPO-NOVI Stock
Select your edition
All financial news and data tailored to specific country editions
